Year |
Citation |
Score |
2016 |
Fayette J, Wirth L, Oprean C, Udrea A, Jimeno A, Rischin D, Nutting C, Harari PM, Csoszi T, Cernea D, O'Brien P, Hanley WD, Kapp AV, Anderson M, Penuel E, et al. Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study). Frontiers in Oncology. 6: 232. PMID 27843803 DOI: 10.3389/fonc.2016.00232 |
0.393 |
|
2006 |
Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R, Konstantopoulos K. Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 337-9. PMID 16352650 DOI: 10.1096/Fj.05-4574Fje |
0.665 |
|
2005 |
Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R. CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity. Cancer Research. 65: 5812-7. PMID 15994957 DOI: 10.1158/0008-5472.Can-04-4557 |
0.661 |
|
2005 |
Napier SL, Hanley WD, Konstantopoulos K. Biophysical and biochemical characterization of selectin-ligand interactions pertinent to metastasis Aiche Annual Meeting, Conference Proceedings. 9125. |
0.733 |
|
2004 |
Hanley WD, Wirtz D, Konstantopoulos K. Distinct kinetic and mechanical properties govern selectin-leukocyte interactions. Journal of Cell Science. 117: 2503-11. PMID 15159451 DOI: 10.1242/Jcs.01088 |
0.676 |
|
2003 |
Konstantopoulos K, Hanley WD, Wirtz D. Receptor-ligand binding: 'catch' bonds finally caught. Current Biology : Cb. 13: R611-3. PMID 12906816 DOI: 10.1016/S0960-9822(03)00529-3 |
0.628 |
|
2003 |
Hanley W, McCarty O, Jadhav S, Tseng Y, Wirtz D, Konstantopoulos K. Single molecule characterization of P-selectin/ligand binding. The Journal of Biological Chemistry. 278: 10556-61. PMID 12522146 DOI: 10.1074/Jbc.M213233200 |
0.611 |
|
Show low-probability matches. |